Maron, S. B., Tsai, C., Strickland, M., Chou, J. F., Roomi, S. R. S., Vanderbilt, C., Tang, L. H., Srivastava, A., Gu, P., Joshi, S. S., Rao, D., Yang, J., Capanu, M., Ku, G. Y., Ilson, D. H., Dayyani, F., Klempner, S. J., Janjigian, Y. Y. (2026). AMIGO: A phase 2 trial of amivantamab in
                    <i>EGFR</i>
                    or
                    <i>MET-</i>
                    amplified gastroesophageal adenocarcinoma (GEA).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.394